IDEX Corporation (NYSE:IEX) is one of the 15 Best Industrial Machinery and Supplies stocks to buy according to Hedge Funds. As of February 3 closing, sentiment around IDEX Corporation (NYSE:IEX) was strongly bullish. The stock had received coverage from 4 analysts, all of whom assigned Buy ratings. The median 1-year price target for the stock is $208.25, as per consensus. Critical Metals (CRML) Jumps 11% on International Expansion Nestor Rizhniak/Shutterstock.com On January 15, the price target on IDEX ...

Gillen said adjusted EBITDA margin for IDEX expanded 40 basis points year-over-year in Q4, driven by productivity gains, favorable price-cost dynamics and cost discipline, which more than offset volume deleverage and unfavorable mix. Adjusted gross margin was flat year-over-year, as price-cost and productivity benefits were offset by volume deleverage and mix. He also noted adjusted EPS came in above the company’s guided range for the quarter.Management said total company organic revenue grew 1% in Q4. Orga ...

IDEX (NYSE:IEX) Q4 2025 Earnings call February 04, 2026 09:00 AM ET Company ParticipantsEric Ashleman - President and CEOJim Giannakouros - VP of Investor RelationsRob Wertheimer - Founding Partner and Director of ResearchSean Gillen - CFOConference Call ParticipantsAndrew Buscaglia - Senior Equity Research AnalystBryan Blair - Managing Director and Senior Equity Research AnalystDeane Dray - Managing Director and Senior Equity AnalystJoe Giordano - Managing Director and Senior Equity Research AnalystMatt Su ...

IDEX (NYSE:IEX) Q4 2025 Earnings call February 04, 2026 09:00 AM ET Company ParticipantsEric Ashleman - President and CEOJim Giannakouros - VP of Investor RelationsRob Wertheimer - Founding Partner and Director of ResearchSean Gillen - CFOConference Call ParticipantsAndrew Buscaglia - Senior Equity Research AnalystBryan Blair - Managing Director and Senior Equity Research AnalystDeane Dray - Managing Director and Senior Equity AnalystJoe Giordano - Managing Director and Senior Equity Research AnalystMatt Su ...

IDEX (NYSE:IEX) Q4 2025 Earnings call February 04, 2026 09:00 AM ET Speaker8Good morning and welcome, everyone, to the IDEX Corporation fourth quarter 2025 earnings conference call. Today's conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press the star key followed by the number one on your telephone keypad. If you would like ...

分组1 - Idex (IEX) reported quarterly earnings of $2.1 per share, exceeding the Zacks Consensus Estimate of $2.04 per share, and showing an increase from $2.04 per share a year ago [1] - The earnings surprise for this quarter was +3.11%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - Idex's revenues for the quarter reached $899.1 million, surpassing the Zacks Consensus Estimate by 1.99%, and an increase from $862.9 million year-over-year [3] 分组2 - The stock has gained approximately 13.3% since the beginning of the year, compared to a 1.1% gain in the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is $1.82 on revenues of $830.11 million, and for the current fiscal year, it is $8.32 on revenues of $3.54 billion [8] - The Manufacturing - General Industrial industry, to which Idex belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook [9]

Fourth Quarter 2025 Earnings February 4, 2026 Click Here to Edit Title Cautionary Statement Click Here to Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, the Company's first quarter 2026 and full year 2026 outlook including expected organic sales and expected ad ...

Sales and Orders - Record sales of $899 million increased 4% on a reported basis and 1% organically for Q4 2025[4] - Record orders of $979 million increased 20% on a reported basis and 16% organically, primarily driven by strength in the HST segment[4] - Total net sales for the quarter ended December 31, 2025, reached $899.1 million, a 4% increase from $862.9 million in the same quarter of 2024[34] - For the year ended December 31, 2025, total net sales were $3,457.5 million, up 6% from $3,268.8 million in 2024[34] - Organic sales growth for the quarter was 1%, with a 5% increase in Health & Science Technologies and a 1% increase in Fluid & Metering Technologies, while Fire & Safety/Diversified Products saw a 5% decline[39] Financial Performance - Net income for the year ended December 31, 2025, was $482.5 million, compared to $504.6 million in 2024, reflecting a decrease of 4.2%[28] - Basic earnings per share attributable to IDEX for 2025 was $6.41, down from $6.66 in 2024[28] - Reported net income attributable to IDEX for Q4 2025 was $128.3 million, slightly up from $123.2 million in Q4 2024, a 0.8% increase[42] - Adjusted net income attributable to IDEX for the quarter was $157.2 million, reflecting an increase from $155.1 million in the prior year[40] - Adjusted net income attributable to IDEX for the year 2025 was $599.5 million, compared to $598.5 million in 2024, indicating a marginal growth of 0.2%[42] Cash Flow and Liquidity - Operating cash flow of $680 million increased 2% and was 141% of net income, up from 132%[4] - Free cash flow of $617 million increased 2% and yielded a conversion of 103%, up from 101%[4] - Cash flows from operating activities for the year ended December 31, 2025, were $680.4 million, compared to $668.1 million in 2024[32] - Cash flows from operating activities for Q4 2025 were $209.5 million, up from $172.6 million in Q4 2024, representing a 21.5% increase[42] - Free cash flow for the year ended December 31, 2025, was $616.8 million, compared to $603.0 million in 2024, reflecting a 2.9% growth[42] Segment Performance - Health & Science Technologies segment net sales increased 9% in Q4 2025, with organic sales up 5%[11] - Fluid & Metering Technologies segment net sales increased 2% in Q4 2025, with organic sales up 1%[15] Cost and Expenses - Corporate costs included in consolidated Adjusted EBITDA were $18.7 million during Q4 2025, relatively flat compared to $20.1 million in the prior year[17] - Adjusted EBITDA margin for Q4 2025 improved due to net productivity enhancements, including platform optimization savings and cost containment[21] - The company incurred restructuring expenses and asset impairments totaling $2.4 million for the quarter[40] - Restructuring expenses and asset impairments for the year ended December 31, 2025, totaled $20.7 million[43] Shareholder Returns - The company utilized $73 million for share repurchases in Q4 2025 and $248 million for the full year[4] - The company repurchased 0.4 million shares at a cost of $75.0 million during the quarter[21] Balance Sheet - Total assets increased to $6,927.0 million as of December 31, 2025, compared to $6,745.3 million in 2024[30] - Total liabilities decreased to $2,900.8 million in 2025 from $2,951.2 million in 2024[30] - IDEX's goodwill increased to $3,414.5 million in 2025 from $3,251.7 million in 2024, indicating ongoing investment in acquisitions[30]

I last covered IDEX Corporation ( IEX ) in May of 2025 and rated the stock a HOLD. At that time, the stock appeared to be trading for a discount, while also offering a decent projected rate of return of aboutI have a masters degree in Analytics from Northwestern University and a bachelors degree in Accounting. I have worked in the investment arena for over 10 years starting as an analyst and working my way up to a management role. Dividend investing is a personal hobby and I look forward to sharing my thoug ...

BT Group share price has remained in a tight range in the past few months as investors assess the recent developments and their impact on its business. It was trading at 182p on Tuesday, a few points ... ...